HALO logo
halo search icon
CU6
Clarity Pharmaceuticals Ltd.

CU6 · Clarity Pharmaceuticals Ltd.

2.21

AUD
-0.01 (-0.45%)
17/06/2026 04:10:10 PM
+1
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

AU$768.32M

PE

0.00

EV/EBITDA

N/A

DIV Yield

0%

Franking

0%

MQV Rating

5Very Weak

As at 17/06/2026 04:10:10 PM

Price Chart

Description

Clarity Pharmaceuticals Ltd. is a clinical stage radiopharmaceutical company. It engages in research and development and clinical stage evaluation of its portfolio of novel radiopharmaceuticals products. The company was founded by Matthew Harris on April 8, 2010 and is headquartered in Eveleigh, Australia.

  • All-Companies
  • All-Consensus
  • Engulfing Bullish
  • GROWTH AUS
  • HALO 200
  • HALO Balance Sheet
  • HALO Consensus Value
  • HALO Ords
  • HALO Small
  • Hammer Bullish
  • Recent Earnings upgrade
  • Short Sold <-1 over the month

Key Fundamentals

EPS 3 yr Growth

110.70%

EBITDA Margin

N/A

Operating Cashflow

-$55m

Free Cash Flow Return

-46.30%

ROIC

-54.40%

Interest Coverage

N/A

Quick Ratio

9.70

Performance

52 weeks range

Low 1.97 - 5.87

Trade Value (12mth)

AU$2,348,542.00

1 week

3.26%

1 month

-14.62%

YTD

-40.16%

1 year

6.73%

All time high

8.98

Additional Data

Shares Outstanding (Fully Diluted)

364m

HALO Sector

Healthcare

Next Company Report Date

26-Aug-26

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

AUD

Short Sell (% of issue)

7.02

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Very Weak

Momentum

Price

Very Weak

Earnings

Strong

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Strong

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

DateEvent
17 June 26ASXD
27 May 26ASXD
20 May 26ASXD
20 May 26ASXD
14 May 26ASXD

See beyond the curve.

One solution for research, investing and portfolio management.
Want to learn more?Frequently asked questions.
1
What is the current share price of Clarity Pharmaceuticals Ltd. (CU6:ASX)?
Halo FAQ
The current share price of Clarity Pharmaceuticals Ltd. (CU6:ASX) is AUD$2.21.
2
What is the 52-week high share price for Clarity Pharmaceuticals Ltd. (CU6:ASX)?
Halo FAQ
The 52-week high share price for Clarity Pharmaceuticals Ltd. (CU6:ASX) is AUD$5.87.
3
What is the 52-week low share price for Clarity Pharmaceuticals Ltd. (CU6:ASX)?
Halo FAQ
The 52-week low share price for Clarity Pharmaceuticals Ltd. (CU6:ASX) is AUD$1.97.
4
What is the dividend yield for Clarity Pharmaceuticals Ltd. (CU6:ASX)?
Halo FAQ
Clarity Pharmaceuticals Ltd. (CU6:ASX) does not pay a dividend.
5
What was Clarity Pharmaceuticals Ltd. (CU6:ASX) last dividend payment?
Halo FAQ
Clarity Pharmaceuticals Ltd. (CU6:ASX) does not pay a dividend.
6
What is the franking level for Clarity Pharmaceuticals Ltd. (CU6:ASX)?
Halo FAQ
Clarity Pharmaceuticals Ltd. (CU6:ASX) has a franking level of 0.00%.
7
In which sector is Clarity Pharmaceuticals Ltd. (CU6:ASX) classified?
Halo FAQ
Clarity Pharmaceuticals Ltd. (CU6:ASX) is classified in the Healthcare.